Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2020

Apr 3, 2020

29875_dirs_2020-04-03_bccf9635-b81d-4eef-b76a-ee06fb86b010.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2020-04-01

Reporting Person: Mayhew Jonathan E. (EVP, Chief Transformation Off)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-01 Common Stock F 763 $58.34 Disposed 15288 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-01 Stock Option $58.61 A 28159 Acquired 2030-04-01 Common Stock (28159) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 10592 Direct
CVS Health Future Fund 401(k) Common Stock 408.3167 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Rights $37.91 2026-02-18 Common Stock (6634) 6634 Direct
Stock Appreciation Rights $45.91 2027-02-16 Common Stock (11333) 11333 Direct
Stock Appreciation Rights $52.42 2027-05-09 Common Stock (3067) 3067 Direct
Stock Option $54.19 2029-04-01 Common Stock (44037) 44037 Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

F2: The number of shares subject to the option were calculated using a 30-day average price.

F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

F4: SARs became exercisable on 2/19/2019.

F5: SARs became exercisable in two equal annual installments beginning on 2/17/2019.

F6: SARs became exercisable in two equal annual installments beginning on 5/10/2019.

F7: Options became exercisable in four equal annual installments, commencing 4/1/2020.